Sort
51,593 grants matching “hepatitis”
Long-Acting, Short-Residing Nanochelators for Iron Overload Therapy
$717,218Hak Soo Choi · Massachusetts General Hospital · R01 · FY2025 · HL
Antigen-Specific NK Cell Memory Against SIV and SIV Vaccines
$717,026Roger Keith Reeves · Beth Israel Deaconess Medical Center · R56 · FY2015 · AI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$716,901James L. Sorensen · University Of California, San Francisco · UG1 · FY2016 · DA
Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates
$716,714Ryan Eugene Temel · University Of Kentucky · R01 · FY2014 · HL
Sleeping Beauty-Mediated Gene Therapy for Hemophilia
$716,704R Scott McIvor · Discovery Genomics, Inc. · R44 · FY2011 · HL
A liver digital twin for personalized cancer therapy
$716,666Emilie Roncali · University Of California At Davis · U01 · FY2025 · CA
MDCT Quantification of hepatic tumor viability for assessment of cancer therapy
$716,642Yin Wu · Iq Medical Imaging, Llc · R42 · FY2019 · CA
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
$716,632Priscilla Y. Hsue · University Of California, San Francisco · R33 · FY2019 · HL
Structure And Assembly Of The Hepatitis B Nucleocapsid Protein
$716,592Paul T Wingfield · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2009 · AR
Chemoprophylaxis for HIV Prevention in Men Supplement
$716,590Robert M. Grant · J. David Gladstone Institutes · U01 · FY2007 · AI
Leveraging the plasma virome as a biological indicator of HIV risk and transmission networks among people who inject drugs
$716,523Abraham Kandathil · Johns Hopkins University · R01 · FY2025 · DA
Photoabsorbing bioinks for expanding 3D printed human liver in situ
$716,386Kelly R Stevens · University Of Washington · R01 · FY2023 · DK
HCV Disease Management in HIV-HCV Coinfected IDUs
$716,284Mark Sebastian Sulkowski · Johns Hopkins University · R01 · FY2014 · DA
Epigenomics of Air Pollution driven Inflammation, Obesity and Insulin Resistance
$716,210Shyam Biswal · Johns Hopkins University · U01 · FY2018 · ES
Research to Improve and Standardize Marmoset Nutrition and Dietary Husbandry
$716,130Suzette D Tardif · Texas Biomedical Research Institute · R24 · FY2016 · OD
Control of Viral Pathogenesis by Regulation of 2-5A Levels
$716,045Susan R. Weiss · University Of Pennsylvania · R01 · FY2013 · AI
Discovery and Characterization of B-Cell Epitopes for Hepatitis C Virus and Ebola Virus
$716,034Benjamin Doranz · Integral Molecular · N01 · FY2016 · AI
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network
$716,028Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2019 · DA
Gamma Delta T cell and microbial modulation to target chronic SIV-associated inflammation
$715,988Namita Rout · Tulane University Of Louisiana · R01 · FY2022 · DK
Adenovirus Protease Regulation and Antiviral Development
$715,982Walter F. Mangel · Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2006 · AI
Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes-Texas Children's Center.
$715,946Fida Bacha · Baylor College Of Medicine · U01 · FY2024 · DK
Evaluation of a community-based education, navigation, and support (CENS) intervention to reduce opioid-related harms among military veterans
$715,845Alexander S Bennett · New York University · R01 · FY2021 · DA
Analysis of immunity, viral adaptation and pathogenesis in a new mouse model of HCV-related rodent hepacivirus infection
$715,770Charles M. Rice · Rockefeller University · R01 · FY2018 · AI
Leveraging community health workers to improve SARS-CoV-2 testing and mitigation among criminal justice-involved individuals accessing a corrections-focused community-based organization
$715,734Matthew Akiyama · Albert Einstein College Of Medicine · R01 · FY2022 · MD
Epigenetic markers of severity in nonalcoholic fatty liver disease
$715,550Johanna K Distefano · Translational Genomics Research Inst · R01 · FY2019 · DK